重症急性呼吸综合征冠状病毒感染肾透析患者监测系统、演变及预后

International journal of nephrology and kidney failure Pub Date : 2021-01-01 DOI:10.16966/2380-5498.209

A. G., Depine Sa, Vélez-Verbel M, Dianda D, G. L., Chaparro Mc, C. J., Vélez-Verbel D, Cotes N, Vargas Wp, Chartouni-Narvaez S, Raad M, Cadena-Bonfanti A, Musso Cg

{"title":"重症急性呼吸综合征冠状病毒感染肾透析患者监测系统、演变及预后","authors":"A. G., Depine Sa, Vélez-Verbel M, Dianda D, G. L., Chaparro Mc, C. J., Vélez-Verbel D, Cotes N, Vargas Wp, Chartouni-Narvaez S, Raad M, Cadena-Bonfanti A, Musso Cg","doi":"10.16966/2380-5498.209","DOIUrl":null,"url":null,"abstract":"Aim: The novel coronavirus disease 2019 (COVID-19) was first described in Wuhan, China, in December 2019. It has since spread worldwide, leading to high morbidity and mortality. Patients with chronic renal failure on dialysis who also have a confirmed diagnosis of active infection represent a risk group because infections are the second cause of death in this group, followed by immunosuppression caused by the weakening of the innate immunity by uremic toxins. This study aimed to describe the clinical characteristics of patients undergoing haemodialysis who also have a confirmed diagnosis for COVID-19 and its association with short-term outcomes.","PeriodicalId":92052,"journal":{"name":"International journal of nephrology and kidney failure","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Monitoring System, Evolution and Prognosis in Renal Patients on Haemodialysis Infected by Severe Acute Respiratory Syndrome Coronavirus 2\",\"authors\":\"A. G., Depine Sa, Vélez-Verbel M, Dianda D, G. L., Chaparro Mc, C. J., Vélez-Verbel D, Cotes N, Vargas Wp, Chartouni-Narvaez S, Raad M, Cadena-Bonfanti A, Musso Cg\",\"doi\":\"10.16966/2380-5498.209\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: The novel coronavirus disease 2019 (COVID-19) was first described in Wuhan, China, in December 2019. It has since spread worldwide, leading to high morbidity and mortality. Patients with chronic renal failure on dialysis who also have a confirmed diagnosis of active infection represent a risk group because infections are the second cause of death in this group, followed by immunosuppression caused by the weakening of the innate immunity by uremic toxins. This study aimed to describe the clinical characteristics of patients undergoing haemodialysis who also have a confirmed diagnosis for COVID-19 and its association with short-term outcomes.\",\"PeriodicalId\":92052,\"journal\":{\"name\":\"International journal of nephrology and kidney failure\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of nephrology and kidney failure\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.16966/2380-5498.209\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of nephrology and kidney failure","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.16966/2380-5498.209","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

目的:2019年12月，新型冠状病毒病(COVID-19)首次在中国武汉被发现。此后，该病在世界范围内蔓延，导致高发病率和死亡率。确诊为活动性感染的透析慢性肾衰竭患者是一个危险群体，因为感染是这一群体的第二大死亡原因，其次是由尿毒症毒素削弱先天免疫引起的免疫抑制。本研究旨在描述确诊为COVID-19的血液透析患者的临床特征及其与短期预后的关系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Monitoring System, Evolution and Prognosis in Renal Patients on Haemodialysis Infected by Severe Acute Respiratory Syndrome Coronavirus 2

Aim: The novel coronavirus disease 2019 (COVID-19) was first described in Wuhan, China, in December 2019. It has since spread worldwide, leading to high morbidity and mortality. Patients with chronic renal failure on dialysis who also have a confirmed diagnosis of active infection represent a risk group because infections are the second cause of death in this group, followed by immunosuppression caused by the weakening of the innate immunity by uremic toxins. This study aimed to describe the clinical characteristics of patients undergoing haemodialysis who also have a confirmed diagnosis for COVID-19 and its association with short-term outcomes.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

International journal of nephrology and kidney failure

自引率

0.00%

发文量